Foralumab reduced microglial activity in people with nonactive SPMS, and this was linked to reductions in proinflammatory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results